Acute Upper GI Bleeding Flashcards
Incidence and mortality of Acute Upper GI bleeding
-Incidence: 40-150/100000
-Mortality 10% overall, 7% new admissions and 25% existing inpatients
-Rising incidence of liver disease
-50% co-morbidity
-28%> 80y
Causes of upper GI bleeding
-Oesophagitis (10%)- usually with hiatus hernia
-Peptic ulcer (35-50%)- NSAIDs, H. pylori
-Vascular malformations (5%)- teleangectasieas
-Aorto-duodenal fistula (0.2%)- aortic graft
-Varices (2-9%)- liver disease, portal vein thrombosis
-Mallory-Weiss tear (5%)- retching
-Cancer of stomach or oesophagus (2%)
-Gastric erosions (10-20%)- NSAIDs, alcohol
-Gastric antral vascular ectasia (GAVE)= watermelon stomach
Management of non-variceal UGI bleeding
-Assessment and resuscitation
-Risk stratification
-Specialist referral
-Treatment
-Review
Clinical presentation of UGI bleed
-Haematemesis
=Fresh red
=Altered blood with clots
=Coffee ground vomiting (viral illness, UTI, stroke, delirium, drug side effects?)
-Melaena
=Black tarry stool (microbiome changes)
=Rarely red/ purple blood (unless severe bleed)
-Fresh blood PR
-Haemodynamic collapse
=Syncope
=Hypovolaemic shock
=Lightheaded/ collapse/ cold/ clammy: hypovolaemia
-Symptoms of anaemia
=Lightheaded
=SOB
=Tired
History of UGI bleed
-History
=Smoker
=Alcohol
=Risk factors for liver disease
=Colonic disease
=Use of aspirin, NSAIDs, antithrombotic, anticoagulants, nicorandil (anti-anginal, irritation of GI tract)
=Symptoms suggestive of ulcer/ previous ulcer/ surgery for ulcer
-Comorbidities
=Cardiovascular
=Respiratory
=Diabetes
-General fitness/ frailty
=Daily activities
=QOL
Examination of UGI bleed
-Shock
=Pulse rate
=BP
=Cold peripheries
=Conscious level
-General
=Stigmata of chronic liver disease
-Abdominal
=Tenderness
=Mass
=Hepatosplenomegaly
-PR
-Raised urea with normal creatinine
Resuscitation of UGI bleed
-ABC
-x2 IV cannula
-Blood: U&Es (GI bleed=large protein load), FBC, LFT, coagulation
-Crossmatch 2-4 units red cells
-IV fluids: 0.9% saline or plasmalyte, platelet transfusion if actively bleeding platelet count less than 50
-fresh frozen plasma to patients who have either a fibrinogen level of less than 1 g/litre, or a prothrombin time (international normalised ratio) or activated partial thromboplastin time greater than 1.5 times normal
-prothrombin complex concentrate to patients who are taking warfarin and actively bleeding
-NEWS
-Correct hypovolaemia
-Restore tissue perfusion
-Prevent multi-organ failure
-IV Crystalloids 500mls <15 minutes
PPI (do not recommend the use of proton pump inhibitors (PPIs) before endoscopy to patients with suspected variceal upper gastrointestinal bleeding although PPIs should be given to patients with non-variceal upper gastrointestinal bleeding and stigmata of recent haemorrhage)
Management of variceal bleeding
terlipressin and prophylactic antibiotics should be given to patients at presentation (i.e. before endoscopy)
band ligation should be used for oesophageal varices and injections of N-butyl-2-cyanoacrylate for patients with gastric varices
transjugular intrahepatic portosystemic shunts (TIPS) should be offered if bleeding from varices is not controlled with the above measures
Describe restrictive transfusion
-Target Hb 70-90g/L
-Increased mortality in major trauma patients if transfused
-Adverse outcomes in cardiac surgery if transfused
-Restrictive vs liberal
=All-cause mortality
=Rebleeding
=Transfusion
What does a risk assessment include?
-Objectively quantify risk of death or intervention
=Early involvement of critical care teams
=Discharge of low-risk patients
=Benchmarking outcomes
=Clinical trials
-Blatchford score vs Rockall score (pre and post endoscopy components, stratify patients according to risk of death)
Describe the Glasgow Blatchford Score
-Score 0-23
-For prediction of intervention
-Score 0-1 can be safely management as outpatients
-Urea, haemoglobin, HR, BP
Pts with score 0 considered for early discharge
Why do people die from upper GI bleeding?
-Hypovolaemia due to rebleeding
-Non-bleeding related causes
=Malignancy
=MOF
=Respiratory
=Cardiac
=CNS
Timing of endoscopy
-Stable patient: endoscopy <24 hrs
-Unstable/ ASA >3: endoscopy <12hrs
=Time spent resuscitating patients is important
Describe Dual modality therapy
-Dilute epinephrine infection (historical)- vasodilation, clotting and coagulation temporarily
-Thermal modality (heater probe)/ mechanical modality (clips)
Describe haemostatic powders
-Hemospray
-Nanopowder- topical procoagulant, primarily dehydration
-Physical barrier
-Rescue therapy